Literature DB >> 18216415

Does the EPR support the discharge process? A study on physicians' use of clinical information systems during discharge of patients with coronary heart disease.

Inger Dybdahl Sørby1, Øystein Nytrø.   

Abstract

This study has been performed in order to categorise and measure usage of different information sources and types in a well defined stage of clinical work. The underlying motivation is to improve computer-supported presentation and retrieval of relevant information and to be able to evaluate the functionality of a future improved interface to the electronic patient record (EPR). By observing 52 discharge processes and categorising information types and sources, we have observed that the paper chart is used as a primary source of information about recent events and procedures, while the EPR is mostly used for retrieving background information and verification. Direct communication with other clinicians and the patient is also important during the discharge process. Results from an additional survey show that the physicians report greater use of the EPR than the result from the observational study. The study clearly indicates that there is a large potential for improved EPR systems that support the physicians in their work regarding discharge of patients, especially in the future planning part of the discharge.

Entities:  

Mesh:

Year:  2006        PMID: 18216415     DOI: 10.1177/183335830503400404

Source DB:  PubMed          Journal:  Health Inf Manag        ISSN: 1833-3583            Impact factor:   3.185


  2 in total

1.  Sepsis prediction, early detection, and identification using clinical text for machine learning: a systematic review.

Authors:  Melissa Y Yan; Lise Tuset Gustad; Øystein Nytrø
Journal:  J Am Med Inform Assoc       Date:  2022-01-29       Impact factor: 4.497

2.  Process evaluation of discharge planning implementation in healthcare using normalization process theory.

Authors:  Sofi Nordmark; Karin Zingmark; Inger Lindberg
Journal:  BMC Med Inform Decis Mak       Date:  2016-04-27       Impact factor: 2.796

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.